The expression of SCNN1 genes is reduced at both the mRNA and protein levels in ccRCC, with the expression levels of SCNN1B and SCNN1G being positively correlated with disease progression and poor clinical outcomes [58]. This evidence concerns the gene SCNN1A and nonpapillary renal cell carcinoma.